ArticleAdvances in therapy2019

Assessing Patient Preferences for Treatment Decisions for New Direct Acting Antiviral (DAA) Therapies for Chronic Hepatitis C Virus Infections.

Tania M Welzel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.